• 
• 
• 
• 
• 

2003

• Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, Braud VM, Allan DS, Makadzange A, Rowland-Jones S, Willcox B, Jones EY, van der Merwe PA, Kumagai I, Maenaka K*. (2003). Human inhibitory receptors ILT2 and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA, 100, 8856-61.
• Zaccai NR, Maenaka K, Maenaka T, Crocker PR, Brossmer R, Kelm S, Jones EY (2003). Structure-guided design of sialic Acid-based siglec inhibitors and crystallographic analysis in complex with sialoadhesin. Structure 11, 557-67.
• Uemura Y, Senju S, Maenaka K, Iwai LK, Fujii S, Tabata H, Tsukamoto H, Hirata S, Chen YZ, Nishimura Y (2003). Systematic analysis of the combinatorial nature of epitopes recognized by TCR leads to identification of mimicry epitopes for glutamic acid decarboxylase 65-specific TCRs. J. Immunol. 170, 947-960.

• Yasushi Uemura, Satoru Senju, Shinji Fujii, Leo Kei Iwai, Katsumi Maenaka, Hiroki Tabata, Takayuki Kanai, Yu-Zhen Chen and Yasuharu Nishimura (2003). Specificity, degeneracy, and molecular mimicry in antigen recognition by HLA-Class II restricted T cell receptors: implications for clinical medicine. Modern Rheumatology, 13, 205-214.
• 前仲　勝実　カラー生化学(マシューズ)　(三浦謹一郎ら訳編)　第6章担当　(2003).

• 
•